See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Dr. Sheri Colberg Interviewed by Scott King

Dr. Sheri Colberg

Dr. Sheri Colberg Interviewed by Scott King

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

A Product For When You Have Low Blood Sugar

Bill Abajian

A Product For When You Have Low Blood Sugar

Type 2 Diabetes Medications

Page 5
Letter of the Week: Joan Hoover Says Amphetamines Should Not Be Prescribed to Stop Onset of Type 2 in Overweight Children
May 22, 2008 | 
Editor's Note: This week's letter is from Joan Hoover, one of our favorite and most outspoken board members. Joan is also our patient advocate advisor. She is a tireless diabetes educator and advocate for people's access to clear, accurate, and unbiased information about the disease. When Joan speaks, we sit up and listen! Her letter is addressed to Editor-in-Chief Scott King and Diabetes Health pharmacy advisory board member R. Keith Campbell. Campbell had commented favorably on news that a doctor had successfully treated obesity in children by prescribing amphetamines.
When Fat Makes You Healthy: Subcutaneous Fat May Produce Beneficial Hormones
May 22, 2008 | 
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Dr. Sheri Colberg Interviewed by Scott King

Dr. Sheri Colberg

Dr. Sheri Colberg Interviewed by Scott King

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

A Product For When You Have Low Blood Sugar

Bill Abajian

A Product For When You Have Low Blood Sugar

Can Byetta Be a Standalone Treatment for Type 2?
Apr 2, 2008 | 
Since its introduction in 2005, Byetta has become “the talk of the town” as one of the most powerful, yet benign, diabetes drugs of the 21st century.
What You Should Know About Type 2 Medications
Feb 12, 2008 | 
U.S. Suspends Study on Intense Blood Sugar Control After Increase in Deaths Among Type 2 Participants
Feb 8, 2008 | 
After seeing an increase in deaths among type 2 participants, the National Heart Lung and Blood Institute (NHLBI) has halted the intense blood sugar control portion of its years-long study on controlling cardiovascular risks to people with diabetes.
Byetta Dusts Insulin In Year-Long Trial
Dec 11, 2007 | 
In a recent randomized study, 69 people with type 2 diabetes who were already taking metformin were given either Byetta or Lantus for a full year. When the results were in, Byetta came out ahead on several fronts.
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.